Project Details
Description
A Multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease.
Status | Finished |
---|---|
Effective start/end date | 5/1/19 → 4/30/21 |
Funding
- IDORSIA PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.